Revenue | ₹22.80Cr |
Net Profits | ₹3.00Cr |
Net Profit Margins | 13.16% |
Indo US Bio-Tech Ltd’s revenue fell -3.31% since last year same period to ₹22.80Cr in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -26.14% fall in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit fell -40.59% since last year same period to ₹3.00Cr in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -13.04% fall in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin fell -38.56% since last year same period to 13.16% in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 17.73% jumped in its net profit margins since last 3-months.
The revenue for Indo US Bio-Tech Ltd in the Q3 results 2025 was ₹22.80Cr.
The net profit for Indo US Bio-Tech Ltd in the Q3 results 2025 was ₹3.00Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2025 was 13.16%.
The revenue for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹23.58Cr.
The net profit for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹5.05Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2024 was 21.42%.